Abstract
Cartilage development and function are dependent on a temporally integrated program of gene expression. With the advent of RNA interference (RNAi), artificial control of these complex programs becomes a possibility, limited only by the ability to regulate and express the RNAi. Using existing methods for production of RNAi's, we have constructed a plasmid-based short hairpin RNA (shRNA) expression system under control of the human pol III H1 promoter and supplemented this promoter with DNA binding sites for the cartilage-specific transcription factor Sox9. The resulting shRNA expression system displays robust, Sox9-dependent gene silencing. Dependence on Sox9 expression was confirmed by electrophoretic mobility shift assays. The ability of the system to regulate heterologously expressed Sox9 was demonstrated by Western blot, as a function of both Sox9 to shRNA ratio, as well as time from transfection. This novel expression system supports auto-regulatory gene silencing, providing a tissue-specific feedback mechanism for temporal control of gene expression. Its applications for both basic mechanistic studies and therapeutic purposes should facilitate the design and implementation of innovative tissue engineering strategies. © 2009 Elsevier Inc. All rights reserved.
Original language | American English |
---|---|
Journal | Plasmid |
Volume | 62 |
State | Published - Jan 1 2009 |
Keywords
- Cell Line
- DNA binding
- Gene Expression Regulation
- Genetic
- Genetic Techniques
- Green Fluorescent Proteins
- Humans
- Inducible gene silencing
- Nucleic Acid Conformation
- Plasmids
- Promoter Regions
- RNA
- RNA interference
- Regulated expression
- SOX9 Transcription Factor
- Small Interfering
- Sox9
- Time Factors
- Tissue-specific
- Western blotting
- article
- binding site
- cartilage
- embryo
- feedback system
- gel mobility shift assay
- gene expression
- gene silencing
- genetic transfection
- human
- human cell
- plasmid
- shRNA
- short hairpin RNA
- tissue engineering
- transcription factor Sox9
Disciplines
- Life Sciences